# Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

Study · id `cardio:ct-nct04665648` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04665648](<https://clinicaltrials.gov/study/NCT04665648>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04665648

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.

## Technical summary

Registry record NCT04665648. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1500 participants (enrolled count; ClinicalTrials.gov record NCT04665648, source copy `cardio:ctgov-nct04665648-2025-03-11`, retrieved 2026-10-26)
- Started: 2021-06-01 (actual) (ClinicalTrials.gov record NCT04665648, source copy `cardio:ctgov-nct04665648-2025-03-11`, retrieved 2026-10-26)
- Primary completion: 2024-12-31 (actual) (ClinicalTrials.gov record NCT04665648, source copy `cardio:ctgov-nct04665648-2025-03-11`, retrieved 2026-10-26)
- Completion: 2024-12-31 (actual) (ClinicalTrials.gov record NCT04665648, source copy `cardio:ctgov-nct04665648-2025-03-11`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04665648, source copy `cardio:ctgov-nct04665648-2025-03-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04665648-2025-03-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention
- Acronym: CLEAN
- Condition: ST Elevation Myocardial Infarction
- Condition: Percutaneous Coronary Intervention
- Intervention (Drug): Nicorandil
- Intervention (Drug): Placebo
- Lead sponsor: Fudan University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Fudan University (`cardio:org-fudan-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial (`cardio:pubmed-42584383`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 784bf8e5d1d9559a43292b26fc9373526ac89726fd373f5594ec9b89f300abd9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
